ArticleCureus2025
Expanding the Phenotypic Spectrum of FOXC1-Related Axenfeld-Rieger Syndrome Type 3: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axenfeld-Rieger syndrome (ARS) is an inherited disorder that commonly affects ocular and other systemic structures. We introduce a case of a male infant who presented to the clinic after genomic microarray testing discovered a chromosomal deletion involving the FOXC1 gene. The patient was found to have anterior segment anomalies, craniofacial differences, auditory insufficiency, and other systemic findings such as an atrial communication defect throughout the first two years of life. Genetic testing performed shortly after birth supported the diagnosis of ARS as the cause of these various findings. This early recognition of ARS permitted prompt initiation of multidisciplinary care and allowed the patient to receive the appropriate ophthalmologic, cranial, renal, cardiac, and developmental testing to provide sufficient care and future monitoring. This case highlights the importance of genetic evaluation and ongoing coordinated care to anticipate and manage the diverse features of patients with ARS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.